Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hirofumi Kurose is active.

Publication


Featured researches published by Hirofumi Kurose.


Calcified Tissue International | 1987

Intranasal absorption of salmon calcitonin

Hirofumi Kurose; Yoshiki Seino; Masaaki Shima; Hiroyuki Tanaka; Makoto Ishida; Kanji Yamaoka; Hyakuji Yabuuchi

SummaryEight normal subjects and 4 children with osteogenesis imperfecta were administered salmon calcitonin (S-CT) intranasally, and the phamacokinetics of S-CT were studied. In the normal subjects, the plasma S-CT concentration showed a dose-dependent increase over a dosage range of 200–400 IU. Maximal plasma concentrations were reached 20–60 min after intranasal administration of S-CT. The plasma calcium concentration was significantly decreased 60 min after the administration. In the children. S-CT was also absorbed through the nasal mucosa. This suggests that nasal spraying may be an efficient method for administration of S-CT.


Bone and Mineral | 1989

Cooperation of synthetic insulin-like growth factor I/somatomedin C and 1,25-dihydroxyvitamin D3 on regulation of function in clonal osteoblastic cells.

Hirofumi Kurose; Yoshiki Seino; Kanji Yamaoka; Hiroyuki Tanaka; Masaaki Shima; Hyakuji Yabuuchi

We investigated the effects of insulin-like growth factor I/somatomedin C (IGF-I/SM-C), and the interaction of IGF-I and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) on mouse clonal osteoblasts, MC3T3-E1. IGF-I stimulated [3H]thymidine incorporation into the DNA of the cells at concentrations of 1.3-130 X 10(-9) M. The alkaline phosphatase (ALP) activity in cultures was also raised by the hormone at the same concentrations. The optimal dose of IGF-I was 13 X 10(-9) M. Co-addition of IGF-I (1.3-130 X 10(-9) M) and 1,25(OH)2D3 (10(-11) to 10(-10) M) to the culture of MC3T3-E1 cells caused a synergistic increase in ALP activity. 25(OH)D3 and 24,25(OH)2D3 showed a similar effect with IGF-I at 1000-2000 times higher concentrations than 1,25(OH)2D3. [3H]Proline incorporation into collagenase digestible protein (CDP) in media was stimulated dose-dependently by IGF-I up to 2.2-fold over the control levels at 130 X 10(-9) M. Addition of 1,25(OH)2D3 (5 X 10(-11) M) and IGF-I further elevated the proline incorporation into CDP. However, the increment in CDP synthesis, induced by the two hormones was less than the increment in ALP activity. Thus, we conclude (1) that IGF-I stimulates both cell replication and differentiated functions in cultured murine osteoblasts and (2) that IGF-I and 1,25(OH)2D3 have the synergistic effect on ALP activity and the additive effect on collagen synthesis in MC3T3-E1 cells.


Bone and Mineral | 1989

Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets

Kanji Yamaoka; Hiroyuki Tanaka; Hirofumi Kurose; Masaaki Shima; Keiichi Ozono; Shigeo Nakajima; Yoshiki Seino

There have been several reports that document abnormal vitamin D metabolism in X-linked hypophosphatemic rickets (XLH). Those reports indicate a blunted renal 25-hydroxyvitamin D-1 alpha-hydroxylase response to a potent stimulator, phosphorus restriction. We examined here its response to phosphate supplementation. Seven normal volunteers and 12 patients with XLH were submitted to single oral phosphate loading. This treatment produced a marked elevation of the serum phosphorus level, with a mild reduction in the serum calcium level. In normal subjects, although the concentrations of intact parathyroid hormone and mid-region parathyroid hormone were increased, with two peaks at 2 and 8 h after treatment, there were no significant changes in vitamin D metabolites including 25-hydroxyvitamin D (25(OH)D), 24,25-dihydroxyvitamin D (24,25(OH)2D) and 1,25-dihydroxyvitamin D (1,25(OH)2D). On the other hand, in the patients with XLH, the serum 1,25(OH)2D level increased from 23.4 +/- 12.0 (mean +/- SD) pg/ml to 44.3 +/- 33.6 pg/ml 6 h after ingestion without any significant change in 25(OH)D or 24,25(OH)2D.


Calcified Tissue International | 1988

Microcarriers facilitate mineralization in MC3T3-E1 cells

Masaaki Shima; Yoshiki Seino; Hiroyuki Tanaka; Hirofumi Kurose; Makoto Ishida; Hyakuji Yabuuchi; Hiroaki Kodama

SummaryMC3T3-E1 cells showed mineral deposits after about 1 week of culture when incubated in the presence of microcarrier beads. These deposits appeared as white spots on the dish surface, and under light microscopy the cells showed multiple cell layers and mineralization around the microcarriers. The deposits stained positive with calcium-specific Von Kossas method. Using conventional assay, alkaline phosphatase activity (ALP) and parathyroid hormone-stimulated intracellular cAMP production were lower in the microcarrier cultures than in the control, but using cytochemical methods, high alkaline phosphatase activity was found around the microcarriers. These results indicate that microcarriers facilitated the formation of multiple cell layers and provided a culture environment for mineralization.


Journal of Bone and Mineral Metabolism | 1988

Treatment of renal osteodystrophy in children with 1αOHD3 and 24, 25(OH)2D3

Keiichi Ohzono; Yoshiki Seino; Makoto Ishida; Kenichi Satomura; Hirofumi Kurose; Hiroyuki Tanaka; Takehisa Yamamoto; Masaaki Shima; Kanji Yamaoka; Hyakuji Yabuuchi; Yoshiyuki Tanaka

Three pediatric patients with renal osteodystrophy were treated with 1αOHD3 and 24, 25(OH)2D3. While serum calcium level significantly decreased, no significant effects were found on serum phosphorus, alkaline phosphatase, parathyroid hormone and urinary excretion of calcium. These results suggest that 24, 25(OH)2D3 may play some roles in bone and mineral metabolism.


Endocrinology | 1990

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] Increases Insulin-Like Growth Factor I (IGF-I) Receptors in Clonal Osteoblastic Cells. Study on Interaction of IGF-I and 1,25-(OH)2D3*

Hirofumi Kurose; Kanji Yamaoka; Shintaro Okada; Shigeo Nakajima; Yoshiki Seino


The Journal of Clinical Endocrinology and Metabolism | 1981

Effect of Dibutyryl Adenosine 3′,5′-Monophosphate Administration on Plasma Concentrations of 1,25-Dihydroxyvitamin D in Pseudohypoparathyroidism Type I*

Kanji Yamaoka; Yoshiki Seino; Makoto Ishida; Tsuneyasu Ishii; Tsunesuke Shimotsuji; Yoshiyuki Tanaka; Hirofumi Kurose; Shunji Matsuda; Kenichi Satomura; Hyakuj Yabuuchi


Biomedical Research-tokyo | 1982

PLASMA CLEARANCE FOR HIGH DOSES OF EXOGENOUS 1,25-DIHYDROXY[23,24(n)- 3 H]CHOLECALCIFEROL IN X-LINKED HYPOPHOSPHATEMIC MICE

Yoshiki Seino; Kanji Yamaoka; Makoto Ishida; Yoshiyuki Tanaka; Hirofumi Kurose; Hyakuji Yabuuchi; Yasuo Tohira; Masafumi Fukushima; Yasuho Nishii


Endocrinology | 1988

Effects of the Administration of Phosphate on Nuclear 1,25-Dihydroxyvitamin D3 Uptake by Duodenal Mucosal Cells of Hyp Mice

Takehisa Yamamoto; Yoshiki Seino; Hiroyuki Tanaka; Kanji Yamaoka; Hirofumi Kurose; Makoto Ishida; Hyakuji Yabuuchi


Journal of Bone and Mineral Metabolism | 1988

Treatment of renal osteodystrophy in children with 1 a OHD 3 and 24, 25(OH) 2</su

Keiichi Ohzono; Yoshiki Seino; Makoto Ishida; Kenichi Satomura; Hirofumi Kurose; Hiroyuki Tanaka; Takehisa Yamamoto; Masaaki Shima; Kanji Yamaoka; Hyakuji Yabuuchi; Yoshiyuki Tanaka

Collaboration


Dive into the Hirofumi Kurose's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshiyuki Tanaka

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge